CSL

📍 Melbourne, Australia👥 21,639 employees💰 Last funded Feb 2026
Biotechnology Research🌐 csl.com
Website LinkedIn
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Denmark
1
Australia
1
Frequently asked questions
Who invested in CSL?
CSL has 2 investors on record on gritt.io.
When did CSL last raise funding?
The most recent investment in CSL recorded on gritt.io was in February 2026.
What industry is CSL in?
CSL operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is CSL based?
CSL is headquartered in Melbourne, Australia.